BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8457326)

  • 21. [Value of rifampicin (Sinerdo1R) in the treatment of pulmonary tuberculosis].
    Ionescu C; Nicolae M; Tănase-Galicescu C
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(4):671-2. PubMed ID: 550255
    [No Abstract]   [Full Text] [Related]  

  • 22. Defective leukotaxis in monocytes from patients with pulmonary tuberculosis.
    Campbell PB
    J Infect Dis; 1979 Apr; 139(4):409-17. PubMed ID: 438541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behaviour of some lysosomal enzymes in the plasma of insulin dependent diabetic patients during artificial pancreas treatment.
    Burlina AB; Goi G; Fabi A; Lombardo A; Gaburro D; Tettamanti G
    Clin Biochem; 1987 Dec; 20(6):423-7. PubMed ID: 3436039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Short-term chemotherapy of pulmonary tuberculosis without previous treatment (results up to July 20th, 1972)].
    Poppe de Figueiredo F
    Bull Int Union Tuberc; 1973 Jun; 48(0):139-40. PubMed ID: 4793667
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of tuberculosis].
    Ben Amar J; Dhahri B; Aouina H; Azzabi S; Baccar MA; El Gharbi L; Bouacha H
    Rev Pneumol Clin; 2015; 71(2-3):122-9. PubMed ID: 25434510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
    Zierski M; Bek E; Long MW; Snider DE
    Am Rev Respir Dis; 1980 Dec; 122(6):879-89. PubMed ID: 7006476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum concentration and urinary elimination of ethambutol administered alone and in combination with rifampin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    J Indian Med Assoc; 1986 Dec; 84(12):376-8. PubMed ID: 3585015
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum beta-N-acetylglucosaminidase and beta-glucuronidase activities in silicosis patients and in workers exposed to silica dust.
    Koskinen H; Järvisalo J; Pitkänen E; Mutanen P; Zitting A
    Br J Dis Chest; 1984 Jul; 78(3):217-24. PubMed ID: 6331485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampin in the treatment of pulmonary tuberculosis.
    Hyde L
    Calif Med; 1972 Dec; 117(6):18-21. PubMed ID: 4635395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
    Daddi G
    Wien Med Wochenschr; 1967 Mar; 117(11):266-8. PubMed ID: 5626324
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 34. Present status of chemotherapy for tuberculosis.
    Grosset JH
    Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
    Tabarsi P; Baghaei P; Hemmati N; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR
    East Mediterr Health J; 2009; 15(6):1346-50. PubMed ID: 20218123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modern tuberculosis therapy].
    Krohn J
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2576-8. PubMed ID: 4772808
    [No Abstract]   [Full Text] [Related]  

  • 40. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
    Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
    Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.